Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 3
2001 1
2002 5
2003 2
2004 3
2005 7
2006 3
2007 3
2008 4
2009 4
2010 5
2011 5
2012 6
2013 8
2014 8
2015 8
2016 7
2017 5
2018 9
2019 13
2020 15
2021 8
2022 13
2023 3
2024 6
2025 17

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

160 results

Results by year

Filters applied: . Clear all
Page 1
HIV T-Cell Vaccines.
Mothe B, Brander C. Mothe B, et al. Adv Exp Med Biol. 2018;1075:31-51. doi: 10.1007/978-981-13-0484-2_2. Adv Exp Med Biol. 2018. PMID: 30030788 Review.
Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021.
Deeks SG, Archin N, Cannon P, Collins S, Jones RB, de Jong MAWP, Lambotte O, Lamplough R, Ndung'u T, Sugarman J, Tiemessen CT, Vandekerckhove L, Lewin SR; International AIDS Society (IAS) Global Scientific Strategy working group. Deeks SG, et al. Nat Med. 2021 Dec;27(12):2085-2098. doi: 10.1038/s41591-021-01590-5. Epub 2021 Dec 1. Nat Med. 2021. PMID: 34848888 Review.
Assessing advances in three decades of clinical antiretroviral therapy on the HIV-1 reservoir.
González-Navarro I, Urrea V, Gálvez C, Garcia-Guerrero MDC, Morón-López S, Puertas MC, Grau E, Mothe B, Bailón L, Miranda C, García F, Leal L, Vandekerckhove L, Marconi VC, Sekaly RP, Clotet B, Martinez-Picado J, Salgado M; NIH Reversing Immune Dysfunction for HIV-1 Eradication (RID-HIV) Collaboratory Group. González-Navarro I, et al. Among authors: mothe b. J Clin Invest. 2024 Nov 29;135(2):e183952. doi: 10.1172/JCI183952. J Clin Invest. 2024. PMID: 39610346 Free PMC article.
SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial).
Sábato S, Benet S, Rogers AJ, Murray TA, Skeans M, Mothe B, Paredes R, Mourad A, Kiweewa F, Kamel D, Jain MK, Lutaakome J, Nalubega MG, Sebudde N, Mylonakis E, Braun DL, Hatlen T, Kimuli I, Kitko C, Mugerwa H, Kitonsa J, Kim K, Tien PC, Highbarger J, McCormack AL, Sanchez A, Murray DD, Babiker AG, Davey VJ, Files DC, Gelijns AC, Higgs ES, Kan VL, Matthews GV, Pett SL, Lane HC, Reilly C, Goodman AL, Lundgren JD, Moltó J; ACTIV-3/VATICO study group and the STRIVE Network. Sábato S, et al. Among authors: mothe b. Sci Rep. 2025 Mar 22;15(1):9882. doi: 10.1038/s41598-025-92742-x. Sci Rep. 2025. PMID: 40118946 Free PMC article. Clinical Trial.
Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial.
Bailón L, Moltó J, Curran A, Cadiñanos J, Carlos Lopez Bernaldo de Quirós J, de Los Santos I, Ambrosioni J, Imaz A, Benet S, Suanzes P, Navarro J, González-García J, Busca C, Pérez-Latorre L, Berenguer J, García-Fraile LJ, Mejía-Abril G, Miró JM, Scévola S, Moreno S, Domingo P, Tian Y, Frankot M, Lim D, Cai Y, Vendrame E, Guo S, Wallin JJ, Geleziunas R, SenGupta D, Alarcón-Soto Y, Leal I, Aranguen A, Garcia-Garcia M, McGowan I, Brander C, Arribas JR, Mothe B; AELIX-003 Study Group. Bailón L, et al. Among authors: mothe b. Nat Commun. 2025 Mar 4;16(1):2146. doi: 10.1038/s41467-025-57284-w. Nat Commun. 2025. PMID: 40038256 Free PMC article. Clinical Trial.
Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies.
Gunst JD, Gohil J, Li JZ, Bosch RJ, White Catherine Seamon A, Chun TW, Mothe B, Gittens K, Praiss L, De Scheerder MA, Vandekerckhove L, Escandón K, Thorkelson A, Schacker T, SenGupta D, Brander C, Papasavvas E, Montaner LJ, Martinez-Picado J, Calin R, Castagna A, Muccini C, de Jong W, Leal L, Garcia F, Gruters RA, Tipoe T, Frater J, Søgaard OS, Fidler S. Gunst JD, et al. Among authors: mothe b. Nat Commun. 2025 Jan 21;16(1):906. doi: 10.1038/s41467-025-56116-1. Nat Commun. 2025. PMID: 39837813 Free PMC article.
Differential Immunodominance Hierarchy of CD8+ T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 Infection.
Adland E, Hill M, Lavandier N, Csala A, Edwards A, Chen F, Radkowski M, Kowalska JD, Paraskevis D, Hatzakis A, Valenzuela-Ponce H, Pfafferott K, Williams I, Pellegrino P, Borrow P, Mori M, Rockstroh J, Prado JG, Mothe B, Dalmau J, Martinez-Picado J, Tudor-Williams G, Frater J, Stryhn A, Buus S, Teran GR, Mallal S, John M, Buchbinder S, Kirk G, Martin J, Michael N, Fellay J, Deeks S, Walker B, Avila-Rios S, Cole D, Brander C, Carrington M, Goulder P. Adland E, et al. Among authors: mothe b. J Virol. 2018 Jan 30;92(4):e01685-17. doi: 10.1128/JVI.01685-17. Print 2018 Feb 15. J Virol. 2018. PMID: 29167337 Free PMC article.
Differential escape patterns within the dominant HLA-B*57:03-restricted HIV Gag epitope reflect distinct clade-specific functional constraints.
Payne RP, Branch S, Kløverpris H, Matthews PC, Koofhethile CK, Strong T, Adland E, Leitman E, Frater J, Ndung'u T, Hunter E, Haubrich R, Mothe B, Edwards A, Riddell L, Chen F, Harrigan PR, Brumme ZL, Mallal S, John M, Jooste JP, Shapiro R, Deeks SG, Walker BD, Brander C, Landis C, Carlson JM, Prado JG, Goulder PJ. Payne RP, et al. Among authors: mothe b. J Virol. 2014 May;88(9):4668-78. doi: 10.1128/JVI.03303-13. Epub 2014 Feb 5. J Virol. 2014. PMID: 24501417 Free PMC article.
160 results